1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Phase 2 Study of Ivosidenib in Previously Treated Japanese Subjects With Nonresectable or Metastatic Cholangiocarcinoma With an IDH1 MutationCholangiocarcinoma Metastatic; Cholangiocarcinoma Non-resectableActive, not recruitingPhase 22025-12-09NCT06081829